Articles tagged with Colorectal Cancer
A study has identified mimecan and TXNDC5 as potential biomarkers for early detection of colorectal cancer. The research found that these proteins are differentially expressed in colorectal adenoma, a precursor lesion to the disease.
Researchers found that personalized behavioral intervention services significantly improved colorectal cancer screening rates in primary care practices. The tailored interventions resulted in increased screenings among patients who were not up-to-date with guidelines, with rates reaching as high as 48%.
New chemotherapy regimens such as irinotecan and oxaliplatin-based treatments have been shown to prolong the survival of patients with advanced colorectal cancer. The meta-analysis found that these regimens can provide an estimated absolute survival benefit of 8-4.7 months for certain patient groups.
A study published in the Journal of the National Cancer Institute found that higher education levels are associated with decreased cancer mortality rates among black and white men and women. The difference in mortality was greatest between those with 12 or fewer years of education and those with more than 12 years. This association is ...
The Canadian mortality rate from colorectal cancer is high due to insufficient screening and prevention measures, resulting in advanced-stage treatments being administered too late. Effective screening tests can prevent the disease by detecting benign polyps, but education programs are necessary to address this issue.
The American Gastroenterological Association has established minimum standards for gastroenterologist performance of CT colonography, requiring at least 75 endoscopically confirmed cases to be interpreted. The guidelines emphasize the importance of training and quality control to ensure accurate screening for colorectal cancer.
Researchers discover that the L1-CAM gene is highly expressed in colorectal cancer cells that have spread to the liver, while normal colon tissue lacks this gene. This finding highlights the importance of L1-CAM in metastasis and opens new avenues for cancer research.
A diet rich in choline, found in red meat, eggs, poultry, and dairy products, may increase the risk of colorectal polyps. Research suggests that higher intake of choline is associated with an elevated risk, contradicting previous expectations.
A University of Minnesota team found that the TOPK enzyme, which regulates cell growth and other functions, promotes transformation in colorectal carcinoma by activating related enzymes. This suggests that drugs targeting TOPK could have anti-cancer benefits.
The Vanderbilt-Ingram Cancer Center has received significant funding from the National Cancer Institute to advance innovative colorectal cancer research. The center will focus on developing diagnostic and therapeutic approaches using high-throughput screening strategies, aiming to identify new treatments for this deadly disease.
Researchers found a 15% reduction in colorectal cancer diagnosis among patients with osteoarthritis who took NSAIDs, consistent with previous findings on pre-cancerous polyps. The study supports the need for further research to identify safe NSAID agents for regular preventive therapy.
Researchers found that patients treated with single-drug therapy had shorter overall survival, but those receiving sequential treatment had similar survival rates to combination therapy regimens. The study results challenge conventional clinical practice and suggest a more gentle approach for some patients.
Researchers found a significant link between genetic variation on chromosome 8 and the risk of colorectal cancer, with individuals carrying the specific marker being 23% more likely to develop the disease. The study suggests that this single genetic variation might account for 14% of colorectal cancer cases in Israel.
Researchers at the University of Southern California have identified a common genetic risk factor for colorectal and prostate cancer. The study found that one variant previously associated with prostate cancer also increases the risk of developing colorectal cancer.
Researchers have found a new virus, NV1020, to be effective against colorectal cancer with minimal side effects. The treatment has shown promising results in reducing tumor masses and improving patient survival.
Researchers at Stanford University School of Medicine have identified cancer stem cells in colorectal tumors, which can propagate and maintain the growth of the tumor. These stem cells have been found to be responsible for the spread of cancer to distant sites and are likely to be responsible when tumors resurface or spread.
A large multicenter study examined circulating tumor cells in patients with metastatic colorectal cancer, showing their predictive value for survival and cancer progression. Patients with fewer than 3 CTCs had superior median survival times compared to those with detectable CTCs.
A study from Massachusetts General Hospital reveals that aspirin's colorectal cancer prevention mechanism depends on the inhibition of COX-2 enzyme. Regular aspirin intake only reduced the incidence of colorectal tumors that overexpress COX-2, highlighting a potential target for personalized treatment strategies.
Researchers have found a significant reduction in the overall colorectal tumor miss rate using advanced colonoscopy technologies, establishing a new benchmark for accurate screening and detection. High levels of C-reactive protein are also associated with increased risk of colorectal adenoma in men, but not in women.
Researchers found that pre-operative CT scans in patients experiencing acute appendicitis symptoms may delay surgery, increasing the risk of appendix rupture. Colonoscopies are recommended over flexible sigmoidoscopy for detecting advanced neoplastic lesions, with notable racial disparities observed.
A study published at Digestive Disease Week found that a lifelong vegetarian diet can reduce the risk of colorectal cancer. Additionally, consuming a fatty soup as an appetizer before dinner may lead to reduced food intake in both lean and obese individuals.
A study published in The Lancet found that long-term aspirin use can reduce the risk of colorectal cancer by 37% overall and 74% after 10-15 years. The benefits are likely to outweigh the risks in individuals at increased risk of colon cancer.
A new study finds that virtual colonoscopy with removal of lesions 6 mm or greater is the most cost-effective colon cancer screening test. The study reveals that targeting smaller lesions has little impact on reducing CRC incidence and increases financial costs, while also leading to adverse events.
A meta-analysis of studies found that controlling for socioeconomic factors reduced racial disparities in colorectal cancer survival. Lower socioeconomic status is linked to poorer health outcomes and reduced access to healthcare.
A daily dose of adult-strength aspirin was associated with a moderate decreased cancer risk, particularly for colorectal, prostate, and breast cancers. However, the effect on other types of cancer was not significant.
Researchers found that cetuximab improved overall survival by 23% and reduced disease progression risk by 32%. The drug targets the EGFR receptor on cancer cells, preventing cell growth and triggering an immune response.
Researchers discovered a gene called Atp5a1 that, when mutated, reduces the incidence of polyps in mice. The mutation leads to decreased levels of Atp5a1 gene expression, which may provide insights into its potential role in human cancer.
A large study found that doubling fat intake is linked to a 15% increase in breast cancer risk, regardless of the type of fat consumed. In contrast, higher consumption of lignans, found in plants and whole grains, may be associated with a reduced risk of postmenopausal breast cancer.
Researchers found simultaneous surgeries on colon and liver may reduce length of hospital stay and surgical complications without compromising long-term survival. In certain patient groups, simultaneous surgery was as safe as separate surgeries, potentially leading to better outcomes.
A new study found that routine colonoscopic surveillance improves survival for colorectal cancer patients. Patients who underwent regular follow-up colonoscopies had better five-year survival rates compared to those who did not receive screenings.
A new immunochemical fecal occult blood test (I-FOBT) shows promise in increasing colon cancer screening rates by being more accurate and convenient than traditional methods. The test uses antibodies to detect human blood in stool, eliminating dietary restrictions and allowing for personalized positivity thresholds.
The American College of Physicians recommends periodic health evaluations to improve patient outcomes and reduce healthcare costs. A new study found that immunochemical FOBT is an effective tool for detecting colorectal cancer, with high sensitivity and specificity rates.
A study found significant disparities in colon cancer screening practices by ethnicity, sex, age, education and income level among Medicare patients. Approximately 18.3% of the sample population had been screened for colon cancer during the study period.
A new study found that hairy cell leukemia survivors have an increased risk of developing certain cancers, including Hodgkin lymphoma and thyroid cancer. Meanwhile, a new test may be able to identify patients with a specific type of gene mutation that indicates an inherited form of colorectal cancer or potential response to certain drugs.
New studies using meta-analysis found a significant link between high vitamin D levels and reduced risk of breast and colorectal cancers. Individuals with the highest blood levels of 25-hydroxyvitamin D had the lowest risk of these cancers, with potential protective effects achievable through diet, supplements, or sunlight exposure.
A new report by the European Society for Medical Oncology warns that Europe's aging population is driving a major increase in cancer cases and deaths. The report estimates that there were 3.2 million new cancer cases diagnosed in 2006, with lung cancer remaining the leading cause of death.
Researchers have discovered a new way to fight colorectal cancer by targeting the 'skeletons' of cancer cells, which enable them to reproduce and spread. High-dose PPARgamma inhibitors destroy cancer cell microtubules, reducing their ability to grow and metastasize.
Recent research suggests that regular statin use is not linked to lower colorectal cancer risk, while folate intake does not appear to impact breast cancer risk. However, monitoring of thyroid function may be necessary for patients taking the medication sunitinib, which can cause fatigue and hypothyroidism.
A new study reveals that health-care delivery, particularly screening tests and surgical treatment, contribute to poorer outcomes for African-American patients with colorectal cancer. The study found that African-Americans were more likely to have advanced disease and received less surgical treatment compared to other ethnicities.
Since expanding screening coverage in 1998, the proportion of patients with colon cancer diagnosed at an early stage has increased. The study found that patients diagnosed during periods with universal coverage were significantly more likely to have early-stage illness than those diagnosed in earlier periods.
A study published in Clinical Gastroenterology and Hepatology found that stool DNA testing can detect colorectal cancer with 88% accuracy, regardless of its stage or location. This non-invasive screening test offers a patient-friendly alternative to traditional colonoscopy.
Researchers found whole-body PET/CT scans accurate in diagnosing colorectal cancer stages, changing patient management in 9% of cases. This non-invasive method offers a single-stage approach, reducing burden on patients and clinicians compared to conventional imaging procedures.
A multicenter study found that medium-sized colon polyps (0.6-0.9 cm) are associated with a significant number of advanced adenomas and cancers. This raises questions about the effectiveness of observational screening methods, which do not remove polyps.
Researchers developed a vaccine that stimulates colorectal cancer patients' immune systems to fight cancerous cells, with 70% of patients producing TNF-alpha and GM-CSF in response. The vaccine works by generating infection-fighting white blood cells called T cells, which destroy cancer cells.
A new set of quality indicators has been created to evaluate the quality of care received by patients undergoing colorectal cancer surgery. The guidelines cover aspects of surgical care, including pre-operative evaluation and post-operative management, to provide a valuable tool for improving patient outcomes.
Researchers identified 142 candidate indicators of quality care for colorectal cancer surgery, including surgical credentials, preoperative evaluation, and postoperative management. The expert panel rated 92 indicators as valid, suggesting these can be used to measure care quality and create improvement programs.
Studies found that colorectal cancer screening rates are increasing among Veterans Affairs patients, while younger veterans with other illnesses may not benefit from screening and may even be harmed. Screening methods include fecal occult blood testing and colonoscopy.
A new study by McGill University researchers has found that a diet low in folate may increase the risk of developing colorectal cancer. The study demonstrates a clear link between low dietary folate and the initiation of colorectal cancer in animal models, with 1 in 4 mice on a folate-deficient diet developing at least one tumour.
A study published in Radiology found that virtual colonoscopy is an accurate screening method for colorectal cancer. The procedure was shown to be safer, faster, less costly, more convenient, and just as effective as optical colonoscopy in detecting polyps and cancers.
A new study found that only 33.3% of patients with locally advanced colorectal cancer received the recommended extensive surgery, which reduces local recurrence and improves survival rates. Aspirin takers with a specific genetic variant showed lower risk of developing colorectal adenomas.
Researchers discovered a new target for future colon cancer treatments, a molecule involved in 85% of colon cancer cases. CTBP's accumulation in tumor cells with APC mutations leads to low retinoic acid production, causing improper cell development.
A new prediction model, MMRpro, assesses a person's probability of carrying a particular defect in mismatch repair genes, which predisposes families to colorectal cancer. The study found that MMRpro outperformed existing assessment tools in identifying mutation carriers and predicting colon cancer risk.
Two studies developed clinical models, PREMM1,2 and MMRpro, to predict the presence of mutations in MLH1 and MSH2 genes associated with Lynch syndrome. The models accurately estimated genetic risk for colorectal cancer, providing a timely tool for identifying and counseling families at risk.
Researchers at the University of Texas Medical Branch at Galveston discovered that curcumin blocks the activity of gastrointestinal hormone neurotensin, implicated in colorectal cancer development. Curcumin reduces IL-8 production, accelerating tumor growth and metastasis.
A new biomarker predicting survival in colorectal carcinomas has been discovered, with thymidylate synthase levels in the nucleus and cytoplasm identified as critical markers. The ratio of nuclear to cytoplasmic TS levels also predicts decreased survival, revealing a new potential biomarker for patients with worse prognosis.
A recent study published in the New England Journal of Medicine found that celecoxib, a commonly used painkiller, significantly reduced the incidence of potentially pre-malignant colorectal polyps by 36% in patients taking a daily dose. The study involved over 1,550 participants and showed a greater effect on advanced adenomas.
The APPROVe trial shows rofecoxib effective in reducing the recurrence of colorectal adenomas, a precursor to colon cancer. Patients taking rofecoxib had a lower recurrence rate (41% vs 55%) and reduced risk of advanced adenomas compared to those on placebo.
A study of over 9,000 Danish residents found that a specific variation in the CHEK2 gene triples a woman's risk of developing breast cancer in her lifetime. Women with this mutation are three times as likely to develop breast cancer as those without it.
A study of low-income housing residents found that those who watched more TV took fewer steps and were less likely to meet the recommended daily step count. The research used pedometers to measure physical activity and was conducted by researchers from Dana-Farber Cancer Institute.
A randomized controlled trial found that low-income Chinese-speaking patients were six times more likely to be screened for colorectal cancer when a clinic-based health educator provided culturally and linguistically appropriate counseling, educational materials, and screening test instructions. The intervention increased fecal occult ...